AI
TECH icon

Atria Investments’s Bio-Techne TECH Stock Holding History

Atria Investments’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$683K Sell
9,671
-404
-4% -$21.8K 0.01% 1341
2026
Q1 		$527K Buy
10,075
+1,205
+14% +$72.3K 0.01% 1421
2025
Q4 		$522K Buy
8,870
+2,797
+46% +$170K 0.01% 1417
2025
Q3 		$338K Sell
6,073
-1,411
-19% -$75.6K ﹤0.01% 1658
2025
Q2 		$385K Buy
7,484
+1,774
+31% +$89.1K ﹤0.01% 1567
2025
Q1 		$335K Sell
5,710
-196
-3% -$13.3K ﹤0.01% 1564
2024
Q4 		$425K Buy
5,906
+21
+0.4% +$1.54K 0.01% 1407
2024
Q3 		$470K Sell
5,885
-903
-13% -$67.9K 0.01% 1361
2024
Q2 		$486K Buy
+6,788
New +$500K 0.01% 1317
2023
Q3 		– Sell
-12,514
Closed -$1.02M – 887
2023
Q2 		$1.02M Buy
+12,514
New +$1.01M 0.02% 814
2022
Q2 		– Sell
-12,364
Closed -$1.34M – 874
2022
Q1 		$1.34M Sell
12,364
-1,884
-13% -$194K 0.02% 722
2021
Q4 		$1.84M Buy
14,248
+436
+3% +$53.4K 0.03% 596
2021
Q3 		$1.67M Buy
13,812
+420
+3% +$51.1K 0.03% 599
2021
Q2 		$1.51M Sell
13,392
-1,456
-10% -$153K 0.03% 613
2021
Q1 		$1.42M Sell
14,848
-780
-5% -$71.2K 0.03% 579
2020
Q4 		$1.24M Buy
+15,628
New +$1.13M 0.03% 596
2020
Q2 		– Sell
-5,796
Closed -$275K – 750
2020
Q1 		$275K Buy
5,796
+1,448
+33% +$72.4K 0.02% 455
2019
Q4 		$239K Buy
+4,348
New +$228K 0.01% 1068
2018
Q4 		– Sell
-5,364
Closed -$274K – 1004
2018
Q3 		$274K Sell
5,364
-188
-3% -$8.33K 0.01% 808
2018
Q2 		$205K Buy
5,552
+4
+0.1% +$153 0.01% 907
2018
Q1 		$209K Buy
+5,548
New +$196K 0.01% 800

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Atria Investments's TECH Position: Q2 2026 in Review

Atria Investments reduced its Bio-Techne (TECH) stake by 4% in Q2 2026, selling an estimated $21.8K and leaving 9,671 shares worth $683K. The position accounts for 0.01% of the portfolio, ranked #1341.

Atria Investments first reported a position in TECH in Q1 2018 and has held it in 21 quarters since. The position peaked at $1.84M in Q4 2021. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Atria Investments held 9,671 shares of Bio-Techne worth $683K as of Q2 2026.
  • Atria Investments sold 404 Bio-Techne shares in Q2 2026, an estimated $21.8K.
  • Bio-Techne made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1341 holding.
  • Atria Investments first reported a position in Bio-Techne in Q1 2018 and has held it in 21 quarters since.
  • Atria Investments's Bio-Techne position peaked at $1.84M in Q4 2021.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.